LifeStance Therapists & Psychiatrists Sammamish
22620 Southeast 4th Street, Suite 130, Sammamish
4.6(82 Google reviews)
United States
7 listed treatment centers serving Sammamish and the surrounding area.
22620 Southeast 4th Street, Suite 130, Sammamish
4.6(82 Google reviews)
22620 Southeast 4th Street, Suite 130, Sammamish
4.6(34 Google reviews)
22620 Southeast 4th Street, Suite 130, Sammamish
4.0(4 Google reviews)
22620 Southeast 4th Street, Suite 130, Sammamish
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from Sammamish.
6.9 miles away · Bellevue
7.9 miles away · Kirkland
4030 Lake Washington Boulevard Northeast, 303, Kirkland
4.8(46 Google reviews)
8 miles away · Kirkland
4020 Lake Washington Boulevard Northeast, Suite 210, Kirkland
5.0(4 Google reviews)
13.3 miles away · Seattle
For people in Sammamish considering SPRAVATO®, costs depend on insurance benefits, the treatment setting, and the services billed. Both the medication and the observed treatment and monitoring visit may generate charges. Ask for an estimate that includes both, rather than assuming a medication estimate represents the entire visit.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medications you took and how you responded. Ask the treatment center what documentation it needs, who submits the authorization request, and whether approval is needed before scheduling. Authorization does not necessarily mean you will have no out-of-pocket costs.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. Washington Medicaid coverage also depends on the plan and treatment setting. Confirm benefits directly with your insurer and ask whether the center can bill your coverage; these are separate questions.
Manufacturer savings programs exist for eligible commercially insured patients, but not for patients using government insurance. Program requirements and covered expenses should be checked before relying on assistance. Savings for medication may not address every charge associated with a visit.
Before starting Spravato, ask the center and insurer:
There is currently no listed SPRAVATO® treatment center in Sammamish on this directory page. The available directory information also provides no other Washington cities with listed centers to point you toward. This does not establish that treatment is unavailable locally. Ask your prescribing clinician or insurer to help locate a treatment setting, then confirm directly that it is SPRAVATO® REMS-certified before making arrangements.
Spravato is not a take-home medication. You administer the nasal spray yourself in a certified healthcare setting under direct observation. Monitoring lasts at least two hours after each dose, so allow additional time for preparation, assessment, and discharge. Some visits may take longer depending on how you are feeling and your clinician's assessment.
The typical labeled schedule begins with twice-weekly visits during weeks 1–4, followed by weekly visits during weeks 5–8. Maintenance visits may be weekly or every two weeks. Your prescriber will individualize your schedule; do not assume that a particular frequency is guaranteed.
Arrange for someone else to take you home after every appointment. You must not drive or operate machinery until the next day after a restful sleep. Ask the center about its transportation and discharge requirements before booking, especially if you plan to use a hired ride rather than a friend or family member.
Consider work leave, childcare, and other responsibilities for treatment days. Coordinate recurring rides early, keep a backup transportation plan, and avoid scheduling tasks that require driving afterward. If transportation becomes unreliable, contact the center rather than planning to drive yourself home.
This directory currently has no listed center in Sammamish, and the supplied listings do not identify other Washington cities to suggest. Ask your clinician or insurer for help finding a setting that provides Spravato. Before scheduling, confirm its SPRAVATO® REMS certification, whether it is accepting patients, and whether it can bill your insurance. Offering treatment alone is not confirmation of certification.
Spravato is FDA-approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your symptoms, treatment history, health conditions, and medications to determine whether it is appropriate.
Coverage depends on your plan and the treatment setting. Prior authorization and documentation of earlier antidepressant trials are common requirements. Ask about both the medication and the observed monitoring visit, since both may be billed. Medicare and Washington Medicaid may cover treatment depending on the plan and setting, but neither coverage nor a center's ability to bill your insurance should be assumed.
You self-administer the nasal spray under direct observation in a REMS-certified healthcare setting. The team monitors you for at least two hours after the dose, including for sedation, dissociation, breathing problems, and blood pressure increases. You cannot take the medication home. Arrange a ride afterward, and do not drive or operate machinery until the next day after a restful sleep.
Discuss sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and blood pressure increases. Spravato also carries boxed warnings about abuse and misuse and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Tell your clinician about your health history and all medications you use so they can assess risks and explain monitoring and safety precautions.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when needed. Its approval for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior requires use with an oral antidepressant. If you need urgent help, call or text 988. In an immediate emergency, call 911 rather than waiting for a treatment appointment.
Approved uses, nearby treatment centers, and medically sourced patient guides.